These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 28296287)

  • 1. Bio-inspired nanomedicine strategies for artificial blood components.
    Sen Gupta A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28296287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancement of platelet-inspired nanomedicine.
    Wang S; Yuan J; Yang J; Li N; Liu R; Luan J; Ye D
    Platelets; 2018 Nov; 29(7):690-694. PubMed ID: 29883255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-inspired nanomedicine in hemostasis thrombosis and thromboinflammation.
    Raghunathan S; Rayes J; Sen Gupta A
    J Thromb Haemost; 2022 Jul; 20(7):1535-1549. PubMed ID: 35435322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin-based Oxygen Carriers: Current State-of-the-art and Novel Molecules.
    Sen Gupta A
    Shock; 2019 Oct; 52(1S Suppl 1):70-83. PubMed ID: 31513123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral chemistry: the chemical functionalization of viral architectures to create new technology.
    Chen Z; Li N; Li S; Dharmarwardana M; Schlimme A; Gassensmith JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):512-34. PubMed ID: 26663821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic plant virology for nanobiotechnology and nanomedicine.
    Steele JFC; Peyret H; Saunders K; Castells-Graells R; Marsian J; Meshcheriakova Y; Lomonossoff GP
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jul; 9(4):. PubMed ID: 28078770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous administration of synthetic platelets (SynthoPlate) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis.
    Dyer MR; Hickman D; Luc N; Haldeman S; Loughran P; Pawlowski C; Sen Gupta A; Neal MD
    J Trauma Acute Care Surg; 2018 Jun; 84(6):917-923. PubMed ID: 29538234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.
    Kelley WJ; Safari H; Lopez-Cazares G; Eniola-Adefeso O
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):909-926. PubMed ID: 27194461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine approaches to improve cancer immunotherapy.
    Qiu H; Min Y; Rodgers Z; Zhang L; Wang AZ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28296286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-based nanoparticles as platform technologies for modern vaccines.
    Lee KL; Twyman RM; Fiering S; Steinmetz NF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):554-78. PubMed ID: 26782096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle formulations of cisplatin for cancer therapy.
    Duan X; He C; Kron SJ; Lin W
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):776-91. PubMed ID: 26848041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-Inspired Intravenous Nanomedicine for Injury-Targeted Direct Delivery of Thrombin to Augment Hemostasis in Coagulopathies.
    Girish A; Jolly K; Alsaadi N; de la Fuente M; Recchione A; An R; Disharoon D; Secunda Z; Raghunathan S; Luc NF; Desai C; Knauss E; Han X; Hu K; Wang H; Sekhon UDS; Rohner N; Gurkan UA; Nieman M; Neal MD; Sen Gupta A
    ACS Nano; 2022 Oct; 16(10):16292-16313. PubMed ID: 35916497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide nanostructures in biomedical technology.
    Feyzizarnagh H; Yoon DY; Goltz M; Kim DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):730-43. PubMed ID: 26846352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.
    Curtis C; Zhang M; Liao R; Wood T; Nance E
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27562224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic approaches to RBC mimicry and oxygen carrier systems.
    Modery-Pawlowski CL; Tian LL; Pan V; Sen Gupta A
    Biomacromolecules; 2013 Apr; 14(4):939-48. PubMed ID: 23452431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.
    Ozcelikkale A; Moon HR; Linnes M; Han B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28198106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Jun; 40(3):197-9. PubMed ID: 22409281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and regulation of exosome-based therapy products.
    Batrakova EV; Kim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.
    Kim HW; Greenburg AG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):537-50. PubMed ID: 17090427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.